APA (7th ed.) Citation

CD, H., J, W., A, G., H, K., C, H., AP, K., . . . WL, S. (2026). Glucagon-Like Peptide-1 Receptor Agonists and Fragility Fracture Risk in Type 2 Diabetes. JAMA network open, 9(7), e2625141. https://doi.org/10.1001/jamanetworkopen.2026.25141

Chicago Style (17th ed.) Citation

CD, Hamad, et al. "Glucagon-Like Peptide-1 Receptor Agonists and Fragility Fracture Risk in Type 2 Diabetes." JAMA Network Open 9, no. 7 (2026): e2625141. https://doi.org/10.1001/jamanetworkopen.2026.25141.

MLA (9th ed.) Citation

CD, Hamad, et al. "Glucagon-Like Peptide-1 Receptor Agonists and Fragility Fracture Risk in Type 2 Diabetes." JAMA Network Open, vol. 9, no. 7, 2026, p. e2625141, https://doi.org/10.1001/jamanetworkopen.2026.25141.